STOCK TITAN
  1. Home
  2. SEC Filings
  3. RYAN
  4. [8-K] RYAN SPECIALTY HOLDINGS, INC. Reports Material Event

Ryan Specialty Q3 2026 organic growth slows to 4%

Full-year guidance retains mid-single-digit organic revenue growth, while the board declared a $0.13 quarterly dividend payable November 24, 2026.

Filing Impact
(High)
Filing Sentiment

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment worksHow the balance works

Form Type
8-K

Rhea-AI Filing Summary

Ryan Specialty Holdings, Inc. reported third-quarter 2026 revenue of $790.0 million, up 4.7% year over year, and net income of $88.0 million, up 40.6%. Organic revenue growth was 4.0%, versus 15.0% a year earlier. Adjusted EBITDAC rose 3.8% to $244.4 million while its margin was 30.9%, down from 31.2%; adjusted diluted EPS rose 8.5% to $0.51.

The company returned approximately $173.7 million to shareholders in the quarter, including $150.0 million in Class A repurchases of 3.5 million shares and $23.7 million in dividends and distributions. It had $150.0 million remaining under its share repurchase authorization as of September 30. The board declared a $0.13 quarterly dividend, payable November 24 to holders of record November 10.

For full-year 2026, Ryan maintained its Organic Revenue Growth Rate guidance in the mid-single digits and guided to an Adjusted EBITDAC Margin that is down modestly compared with the prior year. At September 30, cash and cash equivalents were $168.8 million and outstanding debt principal was $3.7 billion.

1 point · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

0 major · 1 point

How the balance works

Positive

  • Moderate pointQ3 net income rose 40.6% to $88.0 million.

Negative

  • Moderate pointOrganic revenue growth fell to 4.0% from 15.0% in Q3 2025.

Insights

Analyzing...

Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Total revenue $790.0 million Third quarter 2026; up 4.7% year over year
Net income $88.0 million Third quarter 2026; up 40.6% year over year
Organic Revenue Growth Rate 4.0% Third quarter 2026; 15.0% in the prior-year period
Adjusted EBITDAC $244.4 million Third quarter 2026; up 3.8% year over year
Adjusted diluted earnings per share $0.51 per diluted share Third quarter 2026; up 8.5% year over year
Shareholder returns Approximately $173.7 million Third quarter 2026; included $150.0 million of repurchases and $23.7 million in dividends and distributions
Quarterly dividend $0.13 per share Declared October 29, 2026; payable November 24, 2026
Outstanding debt principal $3.7 billion As of September 30, 2026
Organic Revenue Growth Rate financial
"Organic Revenue Growth Rate was 4.0% for the quarter"
Organic revenue growth rate measures how much a company’s sales increase from its existing operations, excluding the effects of acquisitions, divestitures and currency changes. Investors care because it shows whether demand for the company’s products or services is actually expanding on its own — like judging a garden by how much the original plants grew rather than by counting new pots added — which helps assess sustainability of profits and management performance.
Adjusted EBITDAC financial
"Adjusted EBITDAC grew 3.8% to $244.4 million"
Adjusted EBITDAC is a company-provided profitability measure that shows earnings before interest, taxes, depreciation, amortization and specific items often tied to extraordinary events (the “C” typically denotes COVID-related costs), with additional one-time or unusual items removed. Think of it as the company’s view of underlying operating profit — like looking at a car’s engine performance after removing temporary add-ons — which can help investors compare core results across periods but is not governed by standard accounting rules.
Adjusted EBITDAC margin financial
"Adjusted EBITDAC margin for the quarter was 30.9%"
Credit Adjusted EBITDAC financial
"Credit Adjusted EBITDAC is defined as Adjusted EBITDAC"
contingent consideration financial
"Change in contingent consideration"
Contingent consideration is an additional payment agreed when one company buys another that will be paid later only if specific future targets are met, such as revenue, profit, or regulatory milestones. It matters to investors because it shifts risk between buyer and seller and affects the acquiring company's future cash flow and reported value — like promising a bonus after results are proven.
Total revenue $790.0 million Up 4.7% year over year
Net income $88.0 million Up 40.6% year over year
Organic Revenue Growth Rate 4.0% 15.0% in the prior-year period
Adjusted EBITDAC $244.4 million Up 3.8% year over year
Adjusted EBITDAC margin 30.9% 31.2% in the prior-year period
Adjusted diluted earnings per share $0.51 Up 8.5% year over year
Guidance

For full-year 2026, the company maintained its Organic Revenue Growth Rate guidance in the mid-single digits and guided to an Adjusted EBITDAC Margin that is down modestly compared with the prior year.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were RYAN's third-quarter 2026 revenue and net income?
Revenue was $790.0 million, up 4.7% year over year, and net income was $88.0 million, up 40.6%, for the quarter ended September 30, 2026. Adjusted diluted EPS was $0.51, compared with $0.47 in the prior-year quarter.

What is RYAN's quarterly dividend and when is it payable?
Ryan Specialty declared a $0.13 per-share quarterly dividend on outstanding Class A common stock, payable November 24, 2026, to stockholders of record as of the close of business November 10, 2026.

What is RYAN's full-year 2026 guidance?
The company maintained its Organic Revenue Growth Rate guidance in the mid-single digits and guided to an Adjusted EBITDAC Margin that is down modestly compared with the prior year.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Available on EDGAR Accepted by SEC EDGAR
FALSE000184925300018492532026-10-292026-10-2900018492532026-07-302026-07-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
____________________
FORM 8-K
____________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 29, 2026
____________________
RYAN SPECIALTY HOLDINGS, INC.
(Exact name of Registrant as Specified in Its Charter)
____________________
Delaware
001-40645
86-2526344
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
155 North Wacker Drive, Suite 4000
Chicago, Illinois
60606
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 312 784-6001
(Former Name or Former Address, if Changed Since Last Report)
____________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange on which registered
Class A Common Stock, $0.001 par value
RYAN
The New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act
of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition
period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the
Exchange Act. o
Item 2.02 Results of Operations and Financial Condition.
On October 29, 2026, Ryan Specialty Holdings, Inc. (the “Company”) issued a press release announcing its results of
operations for the third quarter ended September 30, 2026. A copy of the press release is furnished as Exhibit 99.1 hereto
and is incorporated herein by reference.
The information furnished herewith pursuant to Item 2.02 of this Current Report, including Exhibit 99.1, shall not be
deemed to be filed for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject
to the liabilities of that section. The information in this current report shall not be incorporated by reference into any
registration statement or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly
set forth by specific reference in such filing.
Item 8.01 Other Events.
On October 29, 2026, the Company's board of directors (the “Board”) declared a regular quarterly dividend of $0.13 per
share on the outstanding Class A common stock. The regular quarterly dividend will be payable on November 24, 2026, to
stockholders of record as of the close of business on November 10, 2026.
Item 9.01 Financial Statements and Exhibits.
(d)Exhibits.
The following exhibits are furnished herewith:
Exhibit No.
Description of Exhibit
99.1
Press Release dated October 29, 2026
104
Cover Page Interactive Data File (formatted as inline XBRL)
Cautionary Note Regarding Forward-Looking Statements
This report contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of
1995 that involve substantial risks and uncertainties. All statements, other than statements of historical fact included in this
report, are forward-looking statements. Forward-looking statements give our current expectations relating to our financial
condition, results of operations, plans, objectives, future performance, and business. You can identify forward-looking
statements by the fact that they do not relate strictly to historical or current facts. These statements may include words such
as “anticipate,” “estimate,” “expect,” “project,” “plan,” “intend,” “believe,” “may,” “will,” “should,” “can have,” “likely,”
and other words and terms of similar meaning in connection with any discussion of the timing or nature of future operating
or financial performance or other events. For example, all statements we make relating to our estimated costs, expenditures,
financial results, any future dividends, our plans, and anticipated cost savings relating to the restructuring plan and the
amount and timing of delivery of annual cost savings are forward-looking statements. All forward-looking statements are
subject to risks and uncertainties that may cause actual results to differ materially from those that we expected, These
forward-looking statements are not guarantees of future performance and involve risks, assumptions and uncertainties,
including, but not limited to, those relating to whether the Company will achieve the associated objectives with its
Program, whether the costs and charges associated with restructuring initiatives will exceed current estimates and forecasts,
its ability to realize expected savings and benefits in the amounts and at the times anticipated, changes in management’s
assumptions, its ability to achieve anticipated financial results, risks associated with acquisitions, divestitures, joint
ventures and strategic investments, outcomes of legal and regulatory matters, and changes in legislation or regulations.
These and other risks, assumptions and uncertainties are described in Item 1A (Risk Factors) of the Company’s most recent
Annual Report on Form 10-K and in other documents that the Company files or furnishes with the Securities and Exchange
Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove
incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements.
Accordingly, you are cautioned not to place undue reliance on these forward-looking statements, which speak only as of
the date they are made. Except to the extent required by law, the Company does not undertake, and expressly disclaims,
any duty or obligation to update publicly any forward-looking statement after the date of this report, whether as a result of
new information, future events, changes in assumptions or otherwise.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.
RYAN SPECIALTY HOLDINGS, INC. (Registrant)
Date:
October 29, 2026
By:
/s/ Janice M. Hamilton
Janice M. Hamilton
Executive Vice President and Chief Financial Officer
1
ryana.jpg
RYAN SPECIALTY REPORTS THIRD QUARTER 2026 RESULTS
- Total Revenue grew 4.7% year-over-year to $790.0 million -
- Organic Revenue Growth Rate* of 4.0% year-over-year -
- Net Income of $88.0 million, or $0.29 per diluted share -
- Adjusted EBITDAC* grew 3.8% year-over-year to $244.4 million -
- Adjusted Net Income* increased 4.1% year-over-year to $137.1 million -
- Adjusted Diluted Earnings Per Share* grew 8.5% to $0.51 per diluted share -
- Returned $173.7 million to shareholders, including $150.0 million of share repurchases and $23.7 million of
dividends and distributions -
October 29, 2026 | CHICAGO, IL — Ryan Specialty Holdings, Inc. (NYSE: RYAN) (“Ryan Specialty” or the “Company”),
a leading international specialty insurance firm, today announced results for the third quarter ended September 30,
2026.
Third Quarter 2026 Highlights
•Revenue grew 4.7% year-over-year to $790.0 million, compared to $754.6 million in the prior-year period
•Organic Revenue Growth Rate* was 4.0% for the quarter, compared to 15.0% in the prior-year period
•Net Income increased 40.6% year-over-year to $88.0 million, compared to $62.6 million in the prior-year period.
Diluted Earnings Per Share was $0.29
•Adjusted EBITDAC* increased 3.8% to $244.4 million, compared to $235.5 million in the prior-year period
•Adjusted EBITDAC Margin* of 30.9%, compared to 31.2% in the prior-year period
•Adjusted Net Income* increased 4.1% to $137.1 million, compared to $131.7 million in the prior-year period
•Adjusted Diluted Earnings Per Share* increased 8.5% to $0.51, compared to $0.47 in the prior-year period
•Returned $173.7 million to shareholders through $150.0 million of Class A common stock repurchases,
representing 3.5 million shares, and $23.7 million in dividends and distributions
“We are proud of our third quarter performance, in light of an increasingly challenging market and against our
toughest year over year comparison,” said Patrick G. Ryan, Founder and Executive Chairman of Ryan Specialty. “We
grew total revenue 4.7%, driven by organic growth of 4.0%. We grew Adjusted EBITDAC by 3.8% and Adjusted
Diluted EPS by 8.5%. We continued investing back into our business, with our second largest hiring class in late 2025,
and displayed disciplined expense management, leading to an Adjusted EBITDAC margin that is down only 30 basis
points year to date. We also returned capital to shareholders of over $500 million through dividends, distributions,
and share repurchases. These results reflect the strength of our brokers and underwriters, and of the durable,
scalable platform we have strategically built. We are confident our team will continue to perform throughout this
cycle and emerge even stronger.”
“Our team delivered in the face of one of the most challenging markets we have ever seen, retaining high levels of
existing business, winning significant new business, and building our pipelines,” added Timothy W. Turner, Chief
Executive Officer of Ryan Specialty. “We continue to deliver for our clients through our differentiated talent, deep
specialty expertise, and independence. We are investing in talent, technology, AI, and data that will widen our moat.
We remain focused on controlling what we can control. We are well-positioned to keep winning and to create long-
term value for our shareholders.”
2
Summary of Third Quarter 2026 Results
Three Months Ended
September 30,
Change
Nine Months Ended
September 30,
Change
(in thousands, except percentages
and per share data)
2026
2025
$
%
2026
2025
$
%
GAAP financial measures
Total revenue
$789,963
$754,577
$35,386
4.7%
$2,501,839
$2,299,913
$201,926
8.8%
Net commissions and fees
775,081
739,552
35,529
4.8
2,460,712
2,256,537
204,175
9.0
Compensation and benefits
484,208
440,434
43,774
9.9
1,511,001
1,355,995
155,006
11.4
General and administrative
106,977
117,589
(10,612)
(9.0)
334,381
330,698
3,683
1.1
Total operating expenses
649,135
643,786
5,349
0.8
2,086,099
1,897,835
188,264
9.9
Operating income
140,828
110,791
30,037
27.1
415,740
402,078
13,662
3.4
Net income
88,048
62,603
25,445
40.6
237,026
182,919
54,107
29.6
Net income attributable to Ryan
Specialty Holdings, Inc.
36,681
31,085
5,596
18.0
96,642
55,419
41,223
74.4
Compensation and benefits
expense ratio (1)
61.3 %
58.4 %
60.4 %
59.0 %
General and administrative
expense ratio (2)
13.5 %
15.6 %
13.4 %
14.4 %
Net income margin (3)
11.1 %
8.3 %
9.5 %
8.0 %
Earnings per share (4)
$0.30
$0.24
$0.77
$0.44
Diluted earnings per share (4)
$0.29
$0.20
$0.74
$0.41
Non-GAAP financial measures*
Organic revenue growth rate
4.0 %
15.0 %
7.3 %
11.4 %
Adjusted compensation and
benefits expense
$443,373
$417,217
$26,156
6.3 %
$1,400,151
$1,268,059
$132,092
10.4 %
Adjusted compensation and
benefits expense ratio
56.1 %
55.3 %
56.0 %
55.1 %
Adjusted general and
administrative expense
$102,144
$101,827
$317
0.3 %
$298,306
$287,414
$10,892
3.8 %
Adjusted general and
administrative expense ratio
12.9 %
13.5 %
11.9 %
12.5 %
Adjusted EBITDAC
$244,446
$235,533
$8,913
3.8 %
$803,383
$744,440
$58,943
7.9 %
Adjusted EBITDAC margin
30.9 %
31.2 %
32.1 %
32.4 %
Adjusted net income
$137,121
$131,704
$5,417
4.1 %
$466,581
$424,225
$42,356
10.0 %
Adjusted net income margin
17.4 %
17.5 %
18.6 %
18.4 %
Adjusted diluted earnings per
share
$0.51
$0.47
$0.04
8.5 %
$1.75
$1.52
$0.23
15.1 %
*For a definition and a reconciliation of Organic revenue growth rate, Adjusted compensation and benefits expense,
Adjusted compensation and benefits expense ratio, Adjusted general and administrative expense, Adjusted general and
administrative expense ratio, Adjusted EBITDAC, Adjusted EBITDAC margin, Adjusted net income, Adjusted net income
margin, and Adjusted diluted earnings per share to the most directly comparable GAAP measure, see “Non-GAAP Financial
Measures and Key Performance Indicators” below.
(1)Compensation and benefits expense ratio is defined as Compensation and benefits divided by Total revenue.
(2)General and administrative expense ratio is defined as General and administrative expense divided by Total revenue.
(3)Net income margin is defined as Net income divided by Total revenue.
(4)See “Note 10, Earnings Per Share” of the unaudited quarterly consolidated financial statements.
3
Third Quarter 2026 Review*
Total revenue for the third quarter of 2026 was $790.0 million, an increase of 4.7% compared to $754.6 million in
the prior-year period. This increase was primarily due to continued organic revenue growth of 4.0%, driven by new
client wins, strong renewal retention, and expanded relationships with existing clients, coupled with continued flow
into the specialty and E&S markets, and modest amounts of revenue from acquisitions completed within the trailing
twelve months ended September 30, 2026. We experienced growth across the majority of our casualty lines, offset
by a moderate decline in our property portfolio.
Total operating expenses for the third quarter of 2026 were $649.1 million, a 0.8% increase compared to $643.8
million in the prior-year period. This increase was primarily due to higher Compensation and benefits expenses
resulting from growth in revenue and an increase in Restructuring and related expense due to the Empower
Program, partially offset by a decrease in Acquisition-related expenses. General and administrative expense
decreased compared to the prior-year period due to a decrease in Acquisition-related expenses, partially offset by
an increase in Restructuring and related expense due to the Empower Program. Change in contingent consideration
also decreased compared to the prior-year period.
Net income for the third quarter of 2026 increased 40.6% to $88.0 million, compared to $62.6 million in the prior-
year period, primarily driven by solid revenue growth and relatively flat Total operating expenses, partially offset by
a higher Income tax expense.
Adjusted EBITDAC grew 3.8% to $244.4 million from $235.5 million in the prior-year period. Adjusted EBITDAC
margin for the quarter was 30.9%, compared to 31.2% in the prior-year period. The increase in Adjusted EBITDAC
was driven primarily by solid revenue growth, partially offset by higher Adjusted compensation and benefits
expense.
Adjusted net income for the third quarter of 2026 increased 4.1% to $137.1 million, compared to $131.7 million in
the prior-year period. Adjusted net income margin was 17.4%, compared to 17.5% in the prior-year period. Adjusted
diluted earnings per share for the third quarter of 2026 increased 8.5% to $0.51, compared to $0.47 in the prior-year
period.
*For the definition of each of the non-GAAP measures referred to above, as well as a reconciliation of such non-GAAP
measures to their most directly comparable GAAP measures, see “Non-GAAP Financial Measures and Key Performance
Indicators” below.
4
Third Quarter 2026 Net Commissions and Fees by Specialty and Revenue by Type
Growth in Net commissions and fees in all specialties was primarily driven by solid organic growth.
Three Months Ended September 30,
(in thousands, except percentages)
2026
% of
total
2025
% of
total
Change
Wholesale Brokerage
$394,283
50.9%
$376,788
50.9%
$17,495
4.6%
Binding Authority
93,012
12.0
89,636
12.1
3,376
3.8
Underwriting Management
287,786
37.1
273,128
37.0
14,658
5.4
Total Net commissions and fees
$775,081
$739,552
$35,529
4.8%
Nine Months Ended September 30,
(in thousands, except percentages)
2026
% of
total
2025
% of
total
Change
Wholesale Brokerage
$1,270,881
51.7%
$1,214,741
53.8%
$56,140
4.6%
Binding Authority
303,182
12.3
286,110
12.7
17,072
6.0
Underwriting Management
886,649
36.0
755,686
33.5
130,963
17.3
Total Net commissions and fees
$2,460,712
$2,256,537
$204,175
9.0%
The following tables set forth our revenue by type of commissions and fees:
Three Months Ended September 30,
(in thousands, except percentages)
2026
% of
total
2025
% of
total
Change
Net commissions and policy fees
$725,761
93.6%
$672,942
91.0%
$52,819
7.8%
Supplemental and contingent
commissions
33,781
4.4
29,782
4.0
3,999
13.4
Loss mitigation and other fees
15,539
2.0
36,828
5.0
(21,289)
(57.8)
Total Net commissions and fees
$775,081
$739,552
$35,529
4.8%
Nine Months Ended September 30,
(in thousands, except percentages)
2026
% of
total
2025
% of
total
Change
Net commissions and policy fees
$2,295,699
93.3%
$2,083,983
92.4%
$211,716
10.2%
Supplemental and contingent
commissions
115,066
4.7
103,185
4.6
11,881
11.5
Loss mitigation and other fees
49,947
2.0
69,369
3.0
(19,422)
(28.0)
Total Net commissions and fees
$2,460,712
$2,256,537
$204,175
9.0%
5
Liquidity and Financial Condition
As of September 30, 2026, the Company had Cash and cash equivalents of $168.8 million and outstanding debt
principal of $3.7 billion.
Capital Return
In the third quarter, the Company returned approximately $173.7 million to shareholders through $150.0 million of
Class A common stock repurchases, representing 3.5 million shares, and $23.7 million in dividends and distributions.
As of September 30, 2026, the Company had $150.0 million of remaining authorization under its share repurchase
program.
Additionally, on October 29, 2026, the Company’s board of directors declared a quarterly dividend of $0.13 per
share on the outstanding Class A common stock. The quarterly dividend will be payable on November 24, 2026, to
stockholders of record as of the close of business on November 10, 2026. A portion of the dividend, $0.06 per share,
will be funded by free cash flow from Ryan Specialty, LLC and will be paid to all holders of the Company’s Class A
common stock and the holders of the LLC Common Units (as defined below).
Full Year 2026 Guidance*
The Company is maintaining its full year 2026 guidance for Organic Revenue Growth Rate and updating its Adjusted
EBITDAC Margin as follows:
•We are guiding to an Organic Revenue Growth Rate in the mid-single digits for 2026
•We are guiding to an Adjusted EBITDAC Margin that is down modestly for 2026, as compared to the prior
year
*For a definition of Organic revenue growth rate and Adjusted EBITDAC margin, see “Non-GAAP Financial Measures and Key
Performance Indicators” below.
Conference Call Information
Ryan Specialty will hold a conference call to discuss the financial results at 4:45pm Eastern Time on October 29,
2026. Interested parties may access the conference call through the live webcast, which can be accessed at https://
ryan-specialty-q3-2026-earnings-call.open-exchange.net/registration or by visiting the Company’s Investor Relations
website. Please join the live webcast at least 10 minutes prior to the scheduled start time.
A webcast replay of the call will be available on the Company’s website at ryanspecialty.com in its Investors section
for one year following the call.
About Ryan Specialty
Founded in 2010, Ryan Specialty (NYSE: RYAN) is a service provider of specialty products and solutions for insurance
brokers, agents, and carriers. Ryan Specialty provides distribution, underwriting, product development,
administration, and risk management services by acting as a wholesale broker and a managing underwriter with
delegated authority from insurance carriers. Our mission is to provide industry-leading innovative specialty
insurance solutions for insurance brokers, agents, and carriers. Learn more at ryanspecialty.com.
Forward-Looking Statements
All statements in this release and in the corresponding earnings call that are not historical are “forward-looking
statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and involve substantial risks
and uncertainties. For example, all statements the Company makes relating to its estimated and projected costs,
expenditures, cash flows, growth rates and financial results, its plans, anticipated amount and timing of cost savings
relating to the restructuring plan, or its plans and objectives for future operations, growth initiatives, or strategies,
6
and the statements under the caption “Full Year 2026 Guidance” are forward-looking statements. Words such as
“anticipate,” “estimate,” “expect,” “project,” “plan,” “intend,” “believe,” “may,” “will,” “should,” “can have,”
“likely,” and variations of such words and similar expressions are intended to identify such forward-looking
statements. All forward-looking statements are subject to risks and uncertainties, known and unknown, that may
cause actual results to differ materially from those that the Company expected. Specific factors that could cause
such a difference include, but are not limited to, those disclosed previously in the Company’s filings with the
Securities and Exchange Commission (“SEC”).
For more detail on the risk factors that may affect the Company’s results, see the section entitled “Risk Factors” in
our most recent Annual Report on Form 10-K filed with the SEC, and in other documents filed with, or furnished to,
the SEC. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove
incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements.
Given these factors, as well as other variables that may affect the Company’s operating results, you are cautioned
not to place undue reliance on these forward-looking statements, not to assume that past financial performance will
be a reliable indicator of future performance, and not to use historical trends to anticipate results or trends in future
periods. The forward-looking statements included in this press release and on the related earnings call relate only to
events as of the date hereof. The Company does not undertake, and expressly disclaims, any duty or obligation to
update publicly any forward-looking statement after the date of this release, whether as a result of new information,
future events, changes in assumptions, or otherwise.
Non-GAAP Financial Measures and Key Performance Indicators
In assessing the performance of the Company’s business, non-GAAP financial measures are used that are derived
from the Company’s consolidated financial information, but which are not presented in the Company’s consolidated
financial statements prepared in accordance with GAAP. The Company considers these non-GAAP financial measures
to be useful metrics for management and investors to facilitate operating performance comparisons from period to
period by excluding potential differences caused by variations in capital structures, tax positions, depreciation,
amortization, and certain other items that the Company believes are not representative of its core business. The
Company uses the following non-GAAP measures for business planning purposes, in measuring performance relative
to that of its competitors, to help investors to understand the nature of the Company’s growth, and to enable
investors to evaluate the run-rate performance of the Company. Non-GAAP financial measures should be viewed as
supplementing, and not as an alternative or substitute for, the consolidated financial statements prepared and
presented in accordance with GAAP. The footnotes to the reconciliation tables below should be read in conjunction
with the unaudited consolidated quarterly financial statements in the Company’s Quarterly Report on Form 10-Q
filed with the SEC. Industry peers may provide similar supplemental information but may not define similarly-named
metrics in the same way and may not make identical adjustments.
Organic revenue growth rate: Organic revenue growth rate represents the percentage change in Net commissions
and fees, as compared to the same period for the prior year, adjusted to eliminate revenue attributable to
acquisitions for the first twelve months of ownership, revenue attributable to sold businesses for the subsequent
twelve months after the sale, and other items such as contingent commissions and the impact of changes in foreign
exchange rates.
Adjusted compensation and benefits expense: Adjusted compensation and benefits expense is defined as
Compensation and benefits expense adjusted to reflect items such as (i) equity-based compensation, (ii) acquisition
and restructuring related compensation expenses, and (iii) other exceptional or non-recurring compensation
expenses, as applicable. The most directly comparable GAAP financial metric is Compensation and benefits expense.
Adjusted general and administrative expense: Adjusted general and administrative expense is defined as General
and administrative expense adjusted to reflect items such as (i) acquisition and restructuring related general and
administrative expenses, and (ii) other exceptional or non-recurring general and administrative expenses, as
applicable. The most directly comparable GAAP financial metric is General and administrative expense.
7
Adjusted compensation and benefits expense ratio: Adjusted compensation and benefits expense ratio is defined
as the Adjusted compensation and benefits expense as a percentage of Total revenue. The most directly comparable
GAAP financial metric is Compensation and benefits expense ratio.
Adjusted general and administrative expense ratio: Adjusted general and administrative expense ratio is defined as
the Adjusted general and administrative expense as a percentage of Total revenue. The most directly comparable
GAAP financial metric is General and administrative expense ratio.
Adjusted EBITDAC: Adjusted EBITDAC is defined as Net income before Interest expense, net, Income tax expense,
Depreciation, Amortization, and Change in contingent consideration, adjusted to reflect items such as (i) equity-
based compensation, (ii) acquisition-related expenses, and (iii) other exceptional or non-recurring items, as
applicable. Acquisition-related expense includes one-time diligence, transaction-related, and integration costs.
Acquisition related long-term incentive compensation arises from long-term incentive plans associated with
acquisitions. These plans require service requirements, and in some cases performance targets, to be met in order to
be earned. Restructuring and related expense consists of compensation and benefits, contractors, professional
services, and license fees related to the Empower Program, which was initiated at the beginning of 2026.
Restructuring expense within general and administrative expense includes costs relating to professional services,
technology and data initiatives, license fees, and third-party contractors, as well as non-cash expenses associated
with the impairment of internally-developed software. Compensation and benefits restructuring costs include
severance as well as employment costs for services rendered between the notification and termination dates and
other termination payments. Amortization and expense is composed of charges related to discontinued prepaid
incentive programs. For the three months ended September 30, 2026, Other non-operating income consisted of $1.0
million of proceeds from the sales of a small non-subscription workers compensation book of business and a small
MGU, $0.1 million of sublease income, and $0.1 million of forfeitures of vested equity awards offset by $0.5 million
of TRA contractual interest and related charges. For the three months ended September 30, 2025, Other non-
operating income consisted of $0.3 million of forfeitures of vested equity awards, $0.2 million of seller
reimbursement of acquisition-related retention incentives, and $0.2 million of sublease income offset by $0.4 million
of TRA contractual interest and related charges. For the nine months ended September 30, 2026, Other non-
operating income consisted of $1.1 million of proceeds from the sales of a small non-subscription workers
compensation book of business and a small MGU, $0.7 million of forfeitures of vested equity awards, $0.4 million of
sublease income, and $0.1 million of seller reimbursement of acquisition-related retention incentives offset by $0.8
million of TRA contractual interest and related charges. For the nine months ended September 30, 2025, Other non-
operating income consisted of $0.6 million of seller reimbursement of acquisition-related retention incentives, $0.4
million of sublease income, and $0.3 million of forfeitures of vested equity awards offset by $0.8 million of TRA
contractual interest and related charges. Equity-based compensation reflects non-cash equity-based expense. IPO
related expenses consist of compensation-related expense primarily related to the expense for new awards issued at
IPO as well as expense related to the revaluation of existing equity awards at IPO.
Adjusted EBITDAC margin: Adjusted EBITDAC margin is defined as Adjusted EBITDAC as a percentage of Total
revenue. The most directly comparable GAAP financial metric is Net income margin.
Adjusted net income: Adjusted net income is defined as tax-effected earnings before amortization and certain items
of income and expense, gains and losses, equity-based compensation, acquisition related long-term incentive
compensation, acquisition-related expenses, costs associated with our IPO, and certain exceptional or non-recurring
items. The Company is subject to United States federal income taxes, in addition to state, local, and foreign taxes,
with respect to its allocable share of any net taxable income of Ryan Specialty, LLC (together with its parent New
Ryan Specialty, LLC and their subsidiaries, the “LLC”). For comparability purposes, this calculation incorporates the
impact of federal and state statutory tax rates on 100% of the Company’s adjusted pre-tax income as if the Company
owned 100% of Ryan Specialty, LLC. The most directly comparable GAAP financial metric is Net income.
Adjusted net income margin: Adjusted net income margin is defined as Adjusted net income as a percentage of
Total revenue. The most directly comparable GAAP financial metric is Net income margin.
Adjusted diluted earnings per share: Adjusted diluted earnings per share is defined as Adjusted net income divided
by diluted shares outstanding after adjusting for the effect if 100% of the outstanding LLC Common Units (“LLC
8
Common Units”), together with the shares of Class B common stock, vested Class C Incentive Units, vested but
unexercised options, and unvested equity awards were exchanged into shares of Class A common stock as if 100% of
unvested equity awards were vested. The most directly comparable GAAP financial metric is Diluted earnings per
share.
Credit Adjusted EBITDAC: Credit Adjusted EBITDAC is defined as Adjusted EBITDAC as further adjusted without
duplication for: acquired EBITDAC from the beginning of the applicable twelve month reference period through the
acquisition close date, certain annualized run rate expected cost savings and initiatives, and certain other
adjustments as permitted in calculating leverage ratios under our debt agreements. The Company presents Credit
Adjusted EBITDAC as an additional measure of liquidity and leverage. The calculation of Credit Adjusted EBITDAC
pursuant to our debt agreements permits certain estimates and assumptions that may differ from actual results.
The summary unaudited consolidated financial data presented for the twelve months ended September 30, 2026,
was derived by adding the consolidated financial data of the Company for the twelve months ended December 31,
2025, to the consolidated financial data of the Company for the nine months ended September 30, 2026, and
subtracting the consolidated financial data of the Company for the nine months ended September 30, 2025. The
summary unaudited consolidated financial data for the twelve months ended September 30, 2026, has been
prepared for illustrative purposes only and is not necessarily representative of our results of operations for any
future period or our financial condition at any future date.
The reconciliation of the above non-GAAP measures to each of their most directly comparable GAAP financial
measure is set forth in the reconciliation table accompanying this release.
With respect to the Organic revenue growth rate and Adjusted EBITDAC margin outlook presented in the “Full Year
2026 Guidance” section of this press release, the Company is unable to provide a comparable outlook for, or a
reconciliation to, Total revenue growth rate or Net income margin because it cannot provide a meaningful or
accurate calculation or estimation of certain reconciling items without unreasonable effort. Its inability to do so is
due to the inherent difficulty in forecasting the timing of items that have not yet occurred and quantifying certain
amounts that are necessary for such reconciliation, including variations in effective tax rate, expenses to be incurred
for acquisition activities, and other one-time or exceptional items.
Contacts:
Investor Relations
Nicholas Mezick
VP, Investor Relations
Ryan Specialty
IR@ryanspecialty.com
Phone: (312) 784-6152
Media Relations
Alice Phillips Topping
SVP, Chief Marketing & Communications Officer
Ryan Specialty
Alice.Topping@ryanspecialty.com
Phone: (312) 635-5976
9
Consolidated Statements of Income (Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in thousands, except percentages and per share data)
2026
2025
2026
2025
Revenue
Net commissions and fees
$775,081
$739,552
$2,460,712
$2,256,537
Fiduciary investment income
14,882
15,025
41,127
43,376
Total revenue
$789,963
$754,577
$2,501,839
$2,299,913
Expenses
Compensation and benefits
484,208
440,434
1,511,001
1,355,995
General and administrative
106,977
117,589
334,381
330,698
Amortization
64,278
70,188
194,005
204,841
Depreciation
4,330
3,607
12,525
9,134
Change in contingent consideration
(10,658)
11,968
34,187
(2,833)
Total operating expenses
$649,135
$643,786
$2,086,099
$1,897,835
Operating income
$140,828
$110,791
$415,740
$402,078
Interest expense, net
57,264
56,344
167,646
169,186
Income from equity method investments
(11,840)
(4,957)
(24,410)
(15,050)
Other non-operating income
(784)
(402)
(1,520)
(636)
Income before income taxes
$96,188
$59,806
$274,024
$248,578
Income tax expense (benefit)
8,140
(2,797)
36,998
65,659
Net income
$88,048
$62,603
$237,026
$182,919
GAAP financial measures
Total revenue
$789,963
$754,577
$2,501,839
$2,299,913
Net commissions and fees
775,081
739,552
2,460,712
2,256,537
Compensation and benefits
484,208
440,434
1,511,001
1,355,995
General and administrative
106,977
117,589
334,381
330,698
Net income
88,048
62,603
237,026
182,919
Compensation and benefits expense ratio (1)
61.3 %
58.4 %
60.4 %
59.0 %
General and administrative expense ratio (2)
13.5 %
15.6 %
13.4 %
14.4 %
Net income margin (3)
11.1 %
8.3 %
9.5 %
8.0 %
Earnings per share (4)
$0.30
$0.24
$0.77
$0.44
Diluted earnings per share (4)
$0.29
$0.20
$0.74
$0.41
Non-GAAP Financial Measures (Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in thousands, except percentages and per share data)
2026
2025
2026
2025
Non-GAAP financial measures*
Organic revenue growth rate
4.0 %
15.0 %
7.3 %
11.4 %
Adjusted compensation and benefits expense
$443,373
$417,217
$1,400,151
$1,268,059
Adjusted compensation and benefits expense ratio
56.1 %
55.3 %
56.0 %
55.1 %
Adjusted general and administrative expense
$102,144
$101,827
$298,306
$287,414
Adjusted general and administrative expense ratio
12.9 %
13.5 %
11.9 %
12.5 %
Adjusted EBITDAC
$244,446
$235,533
$803,383
$744,440
Adjusted EBITDAC margin
30.9 %
31.2 %
32.1 %
32.4 %
Adjusted net income
$137,121
$131,704
$466,581
$424,225
Adjusted net income margin
17.4 %
17.5 %
18.6 %
18.4 %
Adjusted diluted earnings per share
$0.51
$0.47
$1.75
$1.52
10
Consolidated Balance Sheets (Unaudited)
(in thousands, except share and per share data)
September 30,
2026
December 31,
2025
ASSETS
CURRENT ASSETS
Cash and cash equivalents
$168,811
$158,322
Commissions and fees receivable – net
576,111
488,951
Fiduciary cash and receivables
4,935,368
4,298,920
Prepaid incentives – net
28,660
13,550
Other current assets
76,615
100,437
Total current assets
$5,785,565
$5,060,180
NON-CURRENT ASSETS
Goodwill
3,216,252
3,225,021
Customer relationships
1,314,994
1,496,885
Other intangible assets
137,001
119,621
Prepaid incentives – net
26,827
27,849
Equity method investments
109,852
109,982
Property and equipment – net
64,665
69,461
Lease right-of-use assets
126,985
130,480
Deferred tax assets
252,220
310,138
Other non-current assets
9,972
14,554
Total non-current assets
$5,258,768
$5,503,991
TOTAL ASSETS
$11,044,333
$10,564,171
LIABILITIES AND STOCKHOLDERS’ EQUITY
CURRENT LIABILITIES
Accounts payable and accrued liabilities
$308,128
$284,403
Accrued compensation
408,583
519,251
Operating lease liabilities
28,923
25,987
Tax Receivable Agreement liabilities
30,697
—
Short-term debt and current portion of long-term debt
42,433
60,187
Fiduciary liabilities
4,935,368
4,298,920
Total current liabilities
$5,754,132
$5,188,748
NON-CURRENT LIABILITIES
Accrued compensation
90,878
70,096
Operating lease liabilities
150,020
153,089
Long-term debt
3,634,056
3,291,462
Tax Receivable Agreement liabilities
454,391
458,997
Deferred tax liabilities
43,547
49,834
Other non-current liabilities
15,561
97,894
Total non-current liabilities
$4,388,453
$4,121,372
TOTAL LIABILITIES
$10,142,585
$9,310,120
STOCKHOLDERS’ EQUITY
Class A common stock ($0.001 par value; 1,000,000,000 shares authorized, 120,364,827
and 129,603,426 shares issued and outstanding at September 30, 2026 and December
31, 2025, respectively)
120
130
Class B common stock ($0.001 par value; 982,799,265 shares authorized and
132,446,301 shares issued and outstanding at September 30, 2026; 1,000,000,000 shares
authorized and 134,508,885 shares issued and outstanding at December 31, 2025)
132
135
Preferred stock ($0.001 par value; 500,000,000 shares authorized, 0 shares issued and
outstanding at September 30, 2026, and December 31, 2025)
—
—
Additional paid-in capital
271,892
513,610
Retained earnings
166,508
120,353
Accumulated other comprehensive income
8,063
13,845
Total stockholders’ equity attributable to Ryan Specialty Holdings, Inc.
$446,715
$648,073
Non-controlling interests
455,033
605,978
Total stockholders’ equity
$901,748
$1,254,051
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY
$11,044,333
$10,564,171
11
Consolidated Statements of Cash Flows (Unaudited)
Nine Months Ended
September 30,
(in thousands)
2026
2025
CASH FLOWS FROM OPERATING ACTIVITIES
Net income
$237,026
$182,919
Adjustments to reconcile net income to cash flows provided by operating activities:
Income from equity method investments
(24,410)
(15,050)
Amortization
194,005
204,841
Depreciation
12,525
9,134
Prepaid and deferred compensation expense
30,096
33,613
Non-cash equity-based compensation
51,968
50,988
Amortization of deferred debt issuance costs
7,303
7,157
Amortization of interest rate cap premium
—
5,216
Deferred income tax expense
26,782
11,472
Deferred income tax expense from common control reorganization
—
47,978
Loss on Tax Receivable Agreement
834
783
Impairment of internally-developed software
11,704
—
Changes in operating assets and liabilities, net of acquisitions:
Commissions and fees receivable – net
(89,099)
(6,392)
Accrued interest liability
(21,183)
(12,489)
Other current and non-current assets
18,464
19,520
Other current and non-current liabilities
(149,082)
(159,269)
Total cash flows provided by operating activities
$306,933
$380,421
CASH FLOWS FROM INVESTING ACTIVITIES
Business combinations – net of cash acquired and cash held in a fiduciary capacity
—
(636,925)
Capital expenditures
(52,233)
(50,678)
Equity method investment in VSIC
—
(16,561)
Proceeds from sale of equity method investment in VSIC
23,349
—
Asset acquisitions
(1,556)
(3,014)
Total cash flows used in investing activities
$(30,440)
$(707,178)
CASH FLOWS FROM FINANCING ACTIVITIES
Borrowings on Revolving Credit Facility
1,359,030
1,114,872
Repayments on Revolving Credit Facility
(1,008,719)
(990,857)
Debt issuance costs paid
—
(2,889)
Repayment of term debt
(12,750)
(12,750)
Receipt of contingently returnable consideration
3,140
1,927
Payment of contingent consideration
(37,406)
(29,252)
Tax distributions to non-controlling LLC Unitholders
(43,103)
(45,695)
Receipt of taxes related to net share settlement of equity awards
18,831
35,174
Taxes paid related to net share settlement of equity awards
(18,698)
(36,051)
Class A common stock dividends and Dividend Equivalents paid
(50,170)
(46,825)
Distributions and Declared Distributions paid to non-controlling LLC Unitholders
(24,233)
(20,428)
Repurchases of Class A common stock
(450,253)
—
Payments related to Ryan Re preferred units
—
(249)
Net change in fiduciary liabilities
183,520
38,341
Total cash flows provided by (used in) financing activities
$(80,811)
$5,318
Effect of changes in foreign exchange rates on cash, cash equivalents, and cash and cash
equivalents held in a fiduciary capacity
(5,872)
14,507
NET CHANGE IN CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A
FIDUCIARY CAPACITY
$189,810
$(306,932)
CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A FIDUCIARY CAPACITY
—Beginning balance
1,584,470
1,680,805
CASH, CASH EQUIVALENTS, AND CASH AND CASH EQUIVALENTS HELD IN A FIDUCIARY CAPACITY
—Ending balance
$1,774,280
$1,373,873
Reconciliation of cash, cash equivalents, and cash and cash equivalents held in a fiduciary
capacity
Cash and cash equivalents
$168,811
$153,485
Cash and cash equivalents held in a fiduciary capacity
1,605,469
1,220,388
Total cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity
$1,774,280
$1,373,873
12
Reconciliation of Organic Revenue Growth Rate
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in thousands, except percentages)
2026
2025
2026
2025
Current period Net commissions and fees revenue
$775,081
$739,552
$2,460,712
$2,256,537
Less: Current period contingent commissions
(29,107)
(24,310)
(95,629)
(82,164)
Less: Revenue attributable to sold businesses
(55)
(65)
(147)
(354)
Net commissions and fees revenue excluding contingent
commissions
$745,919
$715,177
$2,364,936
$2,174,019
Prior period Net commissions and fees revenue
$739,552
$588,129
$2,256,537
$1,806,264
Less: Prior year contingent commissions
(24,310)
(14,842)
(82,164)
(44,741)
Less: Revenue attributable to sold businesses
(1,161)
(427)
(2,343)
(1,548)
Prior period Net commissions and fees revenue excluding
contingent commissions
$714,081
$572,860
$2,172,030
$1,759,975
Change in Net commissions and fees revenue excluding
contingent commissions
$31,838
$142,317
$192,906
$414,044
Less: Mergers and acquisitions Net commissions and fees
revenue excluding contingent commissions
(3,574)
(55,650)
(30,249)
(212,249)
Impact of change in foreign exchange rates
219
(923)
(3,878)
(1,324)
Organic revenue growth (Non-GAAP)
$28,483
$85,744
$158,779
$200,471
Net commissions and fees revenue growth rate (GAAP)
4.8 %
25.7 %
9.0 %
24.9 %
Less: Impact of contingent commissions (1)
(0.3)
(0.9)
(0.1)
(1.4)
Net commissions and fees revenue excluding contingent
commissions growth rate (2)
4.5 %
24.8 %
8.9 %
23.5 %
Less: Mergers and acquisitions Net commissions and fees
revenue excluding contingent commissions (3)
(0.5)
(9.7)
(1.4)
(12.0)
Impact of change in foreign exchange rates (4)
—
(0.1)
(0.2)
(0.1)
Organic Revenue Growth Rate (Non-GAAP)
4.0 %
15.0 %
7.3 %
11.4 %
(1)Calculated by subtracting Net commissions and fees revenue growth rate from net commissions and fees revenue
excluding contingent commissions growth rate and revenue from sold businesses.
(2)Calculated by dividing the change in Total net commissions and fees revenue excluding contingent commissions by
prior year net commissions and fees excluding contingent commissions and revenue from sold businesses.
(3)Calculated by taking the Mergers and acquisitions Net commissions and fees revenue excluding contingent
commissions, representing the first twelve months of net commissions and fees revenue generated from
acquisitions, divided by prior period net commissions and fees revenue excluding contingent commissions and
revenue from sold businesses.
(4)Calculated by taking the change in foreign exchange rates divided by prior period net commissions and fees
revenue excluding contingent commissions and revenue from sold businesses.
13
Reconciliation of Adjusted Compensation and Benefits Expense to Compensation and Benefits Expense
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in thousands, except percentages)
2026
2025
2026
2025
Total revenue
$789,963
$754,577
$2,501,839
$2,299,913
Compensation and benefits expense
$484,208
$440,434
$1,511,001
$1,355,995
Acquisition-related expense
(625)
(3,583)
(5,885)
(8,546)
Acquisition related long-term incentive compensation
(6,791)
(7,463)
(17,185)
(25,115)
Restructuring and related expense
(19,528)
—
(33,627)
—
Amortization and expense related to discontinued prepaid
incentives
(663)
(981)
(2,185)
(3,287)
Equity-based compensation (1)
(13,105)
(7,432)
(45,825)
(36,854)
IPO related expenses
(123)
(3,758)
(6,143)
(14,134)
Adjusted compensation and benefits expense (2)
$443,373
$417,217
$1,400,151
$1,268,059
Compensation and benefits expense ratio
61.3%
58.4%
60.4%
59.0%
Adjusted compensation and benefits expense ratio
56.1%
55.3%
56.0%
55.1%
(1)For the three months ended September 30, 2026, $9.2 million of expense was reversed associated with certain
performance-based awards. For the three months ended September 30, 2025, $5.8 million of expense was
reversed associated with certain executive performance-based awards. See “Note 9, Equity-Based Compensation”
of the unaudited quarterly consolidated financial statements for additional discussion.
(2)Adjustments made to Compensation and benefits expense are described in the definition of Adjusted EBITDAC in
“Non-GAAP Financial Measures and Key Performance Indicators.”
Reconciliation of Adjusted General and Administrative Expense to General and Administrative Expense
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in thousands, except percentages)
2026
2025
2026
2025
Total revenue
$789,963
$754,577
$2,501,839
$2,299,913
General and administrative expense
$106,977
$117,589
$334,381
$330,698
Acquisition-related expense
(509)
(15,762)
(6,553)
(43,284)
Restructuring and related expense
(4,324)
—
(29,522)
—
Adjusted general and administrative expense (1)
$102,144
$101,827
$298,306
$287,414
General and administrative expense ratio
13.5%
15.6%
13.4%
14.4%
Adjusted general and administrative expense ratio
12.9%
13.5%
11.9%
12.5%
(1)Adjustments made to General and administrative expense are described in the definition of Adjusted EBITDAC in
“Non-GAAP Financial Measures and Key Performance Indicators.”
14
Reconciliation of Adjusted EBITDAC to Net Income
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in thousands, except percentages)
2026
2025
2026
2025
Total revenue
$789,963
$754,577
$2,501,839
$2,299,913
Net income
$88,048
$62,603
$237,026
$182,919
Interest expense, net
57,264
56,344
167,646
169,186
Income tax expense (benefit)
8,140
(2,797)
36,998
65,659
Depreciation
4,330
3,607
12,525
9,134
Amortization
64,278
70,188
194,005
204,841
Change in contingent consideration (1)
(10,658)
11,968
34,187
(2,833)
EBITDAC
$211,402
$201,913
$682,387
$628,906
Acquisition-related expense
1,134
19,345
12,439
51,830
Acquisition related long-term incentive compensation
6,791
7,463
17,185
25,115
Restructuring and related expense
23,852
—
63,149
—
Amortization and expense related to discontinued
prepaid incentives
663
981
2,185
3,287
Other non-operating income
(784)
(402)
(1,520)
(636)
Equity-based compensation
13,105
7,432
45,825
36,854
IPO related expenses
123
3,758
6,143
14,134
Income from equity method investments
(11,840)
(4,957)
(24,410)
(15,050)
Adjusted EBITDAC
$244,446
$235,533
$803,383
$744,440
Net income margin
11.1%
8.3%
9.5%
8.0%
Adjusted EBITDAC margin
30.9%
31.2%
32.1%
32.4%
(1)For the three months ended September 30, 2026, and for the nine months ended September 30, 2025, Change in
contingent consideration included a $12.9 million and $14.3 million, respectively, decrease in valuation of the US
Assure contingent consideration as a result of increased loss ratios impacting projected profit commissions.
15
Reconciliation of Adjusted Net Income to Net Income
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in thousands, except percentages)
2026
2025
2026
2025
Total revenue
$789,963
$754,577
$2,501,839
$2,299,913
Net income
$88,048
$62,603
$237,026
$182,919
Income tax expense (benefit)
8,140
(2,797)
36,998
65,659
Amortization
64,278
70,188
194,005
204,841
Amortization of deferred debt issuance costs (1)
2,447
2,397
7,303
7,157
Change in contingent consideration
(10,658)
11,968
34,187
(2,833)
Acquisition-related expense
1,134
19,345
12,439
51,830
Acquisition related long-term incentive compensation
6,791
7,463
17,185
25,115
Restructuring and related expense
23,852
—
63,149
—
Amortization and expense related to discontinued
prepaid incentives
663
981
2,185
3,287
Other non-operating income
(784)
(402)
(1,520)
(636)
Equity-based compensation
13,105
7,432
45,825
36,854
IPO related expenses
123
3,758
6,143
14,134
Income from equity method investments
(11,840)
(4,957)
(24,410)
(15,050)
Adjusted income before income taxes (2)
$185,299
$177,979
$630,515
$573,277
Adjusted income tax expense (3)
(48,178)
(46,275)
(163,934)
(149,052)
Adjusted net income
$137,121
$131,704
$466,581
$424,225
Net income margin
11.1%
8.3%
9.5%
8.0%
Adjusted net income margin
17.4%
17.5%
18.6%
18.4%
(1)Interest expense, net includes amortization of deferred debt issuance costs.
(2)Adjustments made to Net income are described in the definition of Adjusted EBITDAC in “Non-GAAP Financial
Measures and Key Performance Indicators.”
(3)The Company is subject to United States federal income taxes, in addition to state, local, and foreign taxes, with
respect to our allocable share of any net taxable income of the LLC. For the three and nine months ended
September 30, 2026 and 2025, this calculation of adjusted income tax expense is based on a federal statutory rate
of 21% and a combined state income tax rate net of federal benefits of 5.00% on 100% of our adjusted income
before income taxes as if the Company owned 100% of the LLC.
16
Reconciliation of Adjusted Diluted Earnings per Share to Diluted Earnings per Share
Three Months Ended
September 30,
Nine Months Ended
September 30,
2026
2025
2026
2025
Earnings per share of Class A common stock – diluted
$0.29
$0.20
$0.74
$0.41
Less: Net income attributed to dilutive shares (1)
(0.15)
(0.09)
(0.01)
(0.01)
Plus: Impact of all LLC Common Units exchanged for Class
A shares (2)
0.20
0.12
0.16
0.27
Plus: Adjustments to Adjusted net income (3)
0.18
0.25
0.86
0.88
Plus: Dilutive impact of unvested equity awards (4)
(0.01)
(0.01)
—
(0.03)
Adjusted diluted earnings per share
$0.51
$0.47
$1.75
$1.52
(Share count in ’000)
Weighted-average shares of Class A common stock
outstanding – diluted
262,162
273,462
132,485
138,090
Plus: Impact of all LLC Common Units exchanged for Class
A shares (2)
—
—
133,980
135,644
Plus: Dilutive impact of unvested equity awards (4)
4,172
5,526
(393)
5,407
Adjusted diluted earnings per share diluted share count
266,334
278,988
266,072
279,141
(1)Adjustment removes the impact of Net income attributed to dilutive awards to arrive at Net income attributable to
Ryan Specialty Holdings, Inc. For the three months ended September 30, 2026 and 2025, this removes $38.0 million
and $23.4 million of Net income, respectively, on 262.2 million and 273.5 million Weighted-average shares of Class A
common stock outstanding - diluted, respectively. For the nine months ended September 30, 2026 and 2025, this
removes $1.0 million and $1.2 million of Net income, respectively, on 132.5 million and 138.1 million Weighted-
average shares of Class A common stock outstanding - diluted, respectively. See “Note 10, Earnings Per Share” of the
unaudited quarterly consolidated financial statements.
(2)For comparability purposes, this calculation incorporates the Net income that would be distributable if all LLC
Common Units (together with shares of Class B common stock) were exchanged for shares of Class A common stock.
For the three months ended September 30, 2026 and 2025, this includes $51.4 million and $31.5 million of Net
income, respectively, on 262.2 million and 273.5 million Weighted-average shares of Class A common stock
outstanding - diluted, respectively. For the nine months ended September 30, 2026 and 2025, this includes $140.4
million and $127.5 million of Net income, respectively, on 266.5 million and 273.7 million Weighted-average shares of
Class A common stock outstanding - diluted, respectively. For the three months ended September 30, 2026, 133.3
million weighted-average outstanding LLC Common Units were considered dilutive and included in the 262.2 million
Weighted-average shares of Class A common stock outstanding - diluted. For the three months ended September 30,
2025, 135.5 million weighted-average outstanding LLC Common Units were considered dilutive and included in the
273.5 million Weighted-average shares of Class A common stock outstanding - diluted. See “Note 10, Earnings Per
Share” of the unaudited quarterly consolidated financial statements.
(3)Adjustments to Adjusted net income are described in the footnotes of “Reconciliation of Adjusted Net Income to Net
Income” on 262.2 million and 273.5 million Weighted-average shares of Class A common stock outstanding - diluted
for the three months ended September 30, 2026 and 2025, respectively, and 266.5 million and 273.7 million
Weighted-average shares of Class A common stock outstanding - diluted for the nine months ended September 30,
2026 and 2025, respectively.
(4)For comparability purposes and to be consistent with the treatment of the adjustments to arrive at Adjusted net
income, the dilutive effect of 100% of the outstanding LLC Common Units (together with shares of Class B common
stock) at the end of each period, vested Class C Incentive Units, vested but unexercised options, and unvested equity
awards is calculated using the treasury stock method as if the weighted-average unrecognized cost associated with
the awards was $0 over the period, less any unvested equity awards determined to be dilutive within the Diluted EPS
calculation disclosed in “Note 10, Earnings Per Share” of the unaudited quarterly consolidated financial statements.
For the three months ended September 30, 2026 and 2025, 4.2 million and 5.5 million shares were added to the
calculation, respectively. For the nine months ended September 30, 2026 and 2025, (0.4) million and 5.4 million
shares were added to the calculation, respectively.
17
Reconciliation of Credit Adjusted EBITDAC to Net Income
(in thousands)
Twelve Months Ended
September 30, 2026
Total Revenue
$3,253,052
Net Income
$268,264
Interest expense, net
220,844
Income tax expense
50,366
Depreciation
16,480
Amortization
263,590
Change in contingent consideration
50,142
EBITDAC
$869,686
Acquisition-related expense
32,710
Acquisition related long-term incentive compensation
18,651
Restructuring and related expense
63,149
Amortization and expense related to discontinued prepaid incentives
3,230
Other non-operating loss (income)
(1,576)
Equity-based compensation
58,635
IPO related expenses
11,796
Income from equity method investments
(30,596)
Adjusted EBITDAC (1)
$1,025,685
Credit adjustments (2)
59,731
Credit Adjusted EBITDAC
$1,085,416
(1)Adjustments made to Net income are described in the definition of Adjusted EBITDAC in “Non-GAAP Financial
Measures and Key Performance Indicators”.
(2)Adjustments made to Adjusted EBITDAC represent (without duplication) additional adjustments permitted under
our debt agreements.

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

4 documents

Press Releases

Other Documents

Keep reading

More on RYAN

All RYAN news

Trending in the feed

SNDK
Sandisk Reports Fiscal First Quarter 2027 Financial Results Open the live feed